VAXZEVRIA

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 12604224358c826a
Drug Approval Canada Name: VAXZEVRIA
Product Name: VAXZEVRIA
Status: Cancelled Post Market
Status Date: 2023-12-19
Original Market Date: 2021-04-01
Din: 02510847
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BN02 COVID-19, VIRAL VECTOR, NON-REPLICATING
Atc Name: j 07 bn 02
Aig Number: 0162722001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

CHADOX1-S [RECOMBINANT]

50000000000 VP / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

12604224358c826a

Type

Standard